During the 2022-23 and 2024-25 flu seasons, the incidence of cardiorespiratory hospitalization was 2.25% in the high-dose group and 2.38% in the standard-dose group.
The loss of activity is equivalent to 15% of the US population becoming completely immobile for 1 day.
Adult COVID-19 patients also infected with the flu are 4 times more likely to need mechanical ventilation and 2.4 times more likely to die.
The roadmap offers a powerful opportunity to leverage advances in vaccine science to better protect against influenza, including pandemic flu.
The Influenza Vaccines Roadmaps Initiative newsletter highlights recent news, research, and events pertaining to influenza vaccine R&D.
A database of novel vaccine candidates that are designed to provide broader and more durable protection against influenza viruses.
Help support our work on influenza. Advance the work of CIDRAP in public health preparedness and emerging infectious disease response.
Receive the latest infectious disease information.
(CIDRAP News) Researchers who conducted genetic analyses of hundreds of influenza viruses collected during the 2006-07 flu season found that many different variants circulated in the US at the same time, suggesting that the way each year's epidemic spreads is more complicated than previously suspected.
(CIDRAP News) GlaxoSmithKline, maker of the antiviral drug zanamivir (Relenza), today launched a program designed to help businesses stockpile the drug as a strategy to protect employees in the event of an influenza pandemic.
Editor's Note: CIDRAP's Promising Practices: Pandemic Influenza Preparedness Tools (www.pandemicpractices.org) online database showcases peer-reviewed practices, including useful tools to help others with their planning. This article is one of a series exploring the development of these practices. We hope that describing the process and context of these practices enhances pandemic planning.
(CIDRAP News) Wildlife officials in Rhode Island recently announced that during routine surveillance they detected the low-pathogenic form of H7N3 avian influenza in wild mute swans.
The virus was detected in 4 of 11 swans collected from the Seekonk River, near the Swan Point Cemetery, about 4 miles northeast of Providence, according to an Aug 21 press release from the Rhode Island Department of Environmental Management (DEM).
(CIDRAP News) It was secondary bacterial pneumonianot the influenza virus by itselfthat killed most of the millions who perished in the 1918 flu pandemic, which suggests that current pandemic preparations should include stockpiling of antibiotics and bacterial vaccines, influenza researchers reported this week.
(CIDRAP News) Two national nonprofit health groups are offering local public health departments a shot in the arm for fall influenza vaccination efforts by helping them organize immunization clinics at or near polling places.
(CIDRAP News) A study of the blood of older people who survived the 1918 influenza pandemic reveals that antibodies to the strain have lasted a lifetime and can perhaps be engineered to protect future generations against similar strains.
(CIDRAP News) Scientists have warned it's impossible to predict which avian influenza virus will spark the next pandemic, and while most of the attention has been on highly pathogenic H5N1, one research group is reporting new findings that raise concerns about the threat from the low-pathogenic H9N2 virus.
(CIDRAP News) A new report from the British government ranks pandemic influenza very high on the list of major security threats to the United Kingdom.
(CIDRAP News) Two pharmaceutical companies that are developing a second-generation version of the inhaled antiviral drug zanamivir (Relenza) reported promising phase 2 results showing that one dose was as effective against influenza as a course of oseltamivir (Tamiflu).
